Literature DB >> 23588950

A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection.

Jan J Kootstra1, Pieter U Dijkstra, Hans Rietman, Jaap de Vries, Peter Baas, Jan H B Geertzen, Harald J Hoekstra, Josette E H M Hoekstra-Weebers.   

Abstract

Knowledge about long-term consequences of breast cancer treatment on shoulder and arm function and volume in stages I-II breast cancer survivors is limited. The effects of shoulder-arm function shortly after surgery on long-term function are unknown. One hundred and ninety-four women were examined pre-surgery (T0) and 6 weeks after surgery (T1). Of those, 110 were re-examined 7 years later (T2). Thirty-four women underwent sentinel lymph node biopsy (SLNB) and 76 underwent axillary lymph node dissection (ALND). Differences between affected and unaffected side were calculated for four ranges of motion functions, three strength functions and arm volume. These were used to analyse time and group effects. Differences exceeding 20° in range of motion, 20 % in strength and 200 ml in arm volume were considered clinically relevant. Multivariate regression analyses examined the effect of shoulder-arm function at T1 on shoulder-arm function at T2. Additional predictor variables included were age, follow-up time, Body Mass Index, complications, chemotherapy, radiation, SLNB/ALND and type of breast surgery. At T2, range of motion (except external rotation), abduction strength and arm volume were impaired compared to T0. After ALND, women had significantly more forward flexion impairment, increased arm volume and clinically relevant impairments (70 %) than after SLNB (41 %). T1 external rotation, abduction-external rotation, grip strength and arm volume were the strongest predictors of these variables at T2. Age was the strongest predictor of the remaining four variables. ALND predicted arm volume only. Seven years after breast cancer surgery, two-fifth of the women after SLNB and seven out of ten women after ALND had impairments. Impairments were found in five of eight shoulder-arm functions. After SLNB, women have less forward flexion impairment and less arm volume increase than after ALND. Shoulder-arm function at 6 weeks after surgery and age are the strongest predictors of long-term shoulder-arm function.

Entities:  

Mesh:

Year:  2013        PMID: 23588950     DOI: 10.1007/s10549-013-2509-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  26 in total

Review 1.  A Focused Review of Safety Considerations in Cancer Rehabilitation.

Authors:  Susan Maltser; Adrian Cristian; Julie K Silver; G Stephen Morris; Nicole L Stout
Journal:  PM R       Date:  2017-09       Impact factor: 2.298

2.  Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB.

Authors:  Roser Belmonte; Monique Messaggi-Sartor; Montse Ferrer; Angels Pont; Ferran Escalada
Journal:  Support Care Cancer       Date:  2018-04-12       Impact factor: 3.603

3.  Persistent breast pain following breast cancer surgery is associated with persistent sensory changes, pain interference, and functional impairments.

Authors:  Dale J Langford; Steven M Paul; Claudia West; Jon D Levine; Deborah Hamolsky; Charles Elboim; Brian L Schmidt; Bruce A Cooper; Gary Abrams; Bradley E Aouizerat; Christine Miaskowski
Journal:  J Pain       Date:  2014-12       Impact factor: 5.820

4.  Persistent arm pain is distinct from persistent breast pain following breast cancer surgery.

Authors:  Dale J Langford; Steven M Paul; Claudia West; Gary Abrams; Charles Elboim; Jon D Levine; Deborah Hamolsky; Judith A Luce; Kord M Kober; John M Neuhaus; Bruce A Cooper; Bradley E Aouizerat; Christine Miaskowski
Journal:  J Pain       Date:  2014-12       Impact factor: 5.820

5.  Prevalence of shoulder morbidity after treatment for breast Cancer in South Africa.

Authors:  Nicky Kramer; Jo Ramjith; Delva Shamley
Journal:  Support Care Cancer       Date:  2018-11-19       Impact factor: 3.603

6.  Prevalence and risk factors of adhesive capsulitis of the shoulder after breast cancer treatment.

Authors:  Seoyon Yang; Dae Hwan Park; Sei Hyun Ahn; Jisun Kim; Jong Won Lee; Jun Young Han; Dong Kyu Kim; Jae Yong Jeon; Kyoung Hyo Choi; Won Kim
Journal:  Support Care Cancer       Date:  2016-12-09       Impact factor: 3.603

7.  Factors associated with upper limb dysfunction in breast cancer survivors.

Authors:  Thais Cristina Siqueira; Simone Pedrozo Frágoas; Andreia Pelegrini; Ana Rosa de Oliveira; Clarissa Medeiros da Luz
Journal:  Support Care Cancer       Date:  2020-08-17       Impact factor: 3.603

8.  Predictors of Altered Upper Extremity Function During the First Year After Breast Cancer Treatment.

Authors:  Betty Smoot; Steven M Paul; Bradley E Aouizerat; Laura Dunn; Charles Elboim; Brian Schmidt; Deborah Hamolsky; Jon D Levine; Gary Abrams; Judy Mastick; Kimberly Topp; Christine Miaskowski
Journal:  Am J Phys Med Rehabil       Date:  2016-09       Impact factor: 2.159

9.  Normative Values for the Unsupported Upper Limb Exercise Test and 6-Minute Pegboard and Ring Test in Healthy Canadian Adults.

Authors:  Vanessa Pereira Lima; Dina Brooks; Stacey Konidis; Tamara Araújo; Giane Amorim Ribeiro-Samora; Roger Goldstein; Tania Janaudis-Ferreira
Journal:  Physiother Can       Date:  2020-11-01       Impact factor: 1.037

10.  Regulatory VCAN polymorphism is associated with shoulder pain and disability in breast cancer survivors.

Authors:  Trevor S Mafu; Alison V September; Delva Shamley
Journal:  Hum Genomics       Date:  2021-06-23       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.